Validated spectrofluorimetric methods for the determination of apixaban and tirofiban hydrochloride in pharmaceutical formulations

Apixaban and Tirofiban Hydrochloride are low molecular weight anticoagulants. The two drugs exhibit native fluorescence that allow the development of simple and valid spectrofluorimetric methods for the determination of Apixaban at λ ex/λ em=284/450nm and tirofiban HCl at λ ex/λ em=227/300nm in aque...

Full description

Saved in:
Bibliographic Details
Published inSpectrochimica acta. Part A, Molecular and biomolecular spectroscopy Vol. 174; pp. 326 - 330
Main Authors El-Bagary, Ramzia I., Elkady, Ehab F., Farid, Naira A., Youssef, Nadia F.
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 05.03.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Apixaban and Tirofiban Hydrochloride are low molecular weight anticoagulants. The two drugs exhibit native fluorescence that allow the development of simple and valid spectrofluorimetric methods for the determination of Apixaban at λ ex/λ em=284/450nm and tirofiban HCl at λ ex/λ em=227/300nm in aqueous media. Different experimental parameters affecting fluorescence intensities were carefully studied and optimized. The fluorescence intensity-concentration plots were linear over the ranges of 0.2–6μgml−1 for apixaban and 0.2–5μgml−1 for tirofiban HCl. The limits of detection were 0.017 and 0.019μgml−1 and quantification limits were 0.057 and 0.066μgml−1 for apixaban and tirofiban HCl, respectively. The fluorescence quantum yield of apixaban and tirofiban were calculated with values of 0.43 and 0.49. Method validation was evaluated for linearity, specificity, accuracy, precision and robustness as per ICH guidelines. The proposed spectrofluorimetric methods were successfully applied for the determination of apixaban in Eliquis tablets and tirofiban HCl in Aggrastat intravenous infusion. Tolerance ratio was tested to study the effect of foreign interferences from dosage forms excipients. Using Student's t and F tests, revealed no statistically difference between the developed spectrofluorimetric methods and the comparison methods regarding the accuracy and precision, so can be contributed to the analysis of apixaban and tirofiban HCl in QC laboratories as an alternative method. [Display omitted] •New validated spectrofluorimetric methods for the analysis of selected anticoagulants.•The developed methods are successfully applied for the analysis of selected drugs in drug substances and drug products.•The methods are based on the measurements of the native fluorescence of selected drugs.•The proposed methods can be used as alternative methods in quality control laboratories.
AbstractList Apixaban and Tirofiban Hydrochloride are low molecular weight anticoagulants. The two drugs exhibit native fluorescence that allow the development of simple and valid spectrofluorimetric methods for the determination of Apixaban at λ ex/λ em=284/450nm and tirofiban HCl at λ ex/λ em=227/300nm in aqueous media. Different experimental parameters affecting fluorescence intensities were carefully studied and optimized. The fluorescence intensity-concentration plots were linear over the ranges of 0.2-6μgml for apixaban and 0.2-5μgml for tirofiban HCl. The limits of detection were 0.017 and 0.019μgml and quantification limits were 0.057 and 0.066μgml for apixaban and tirofiban HCl, respectively. The fluorescence quantum yield of apixaban and tirofiban were calculated with values of 0.43 and 0.49. Method validation was evaluated for linearity, specificity, accuracy, precision and robustness as per ICH guidelines. The proposed spectrofluorimetric methods were successfully applied for the determination of apixaban in Eliquis tablets and tirofiban HCl in Aggrastat intravenous infusion. Tolerance ratio was tested to study the effect of foreign interferences from dosage forms excipients. Using Student's t and F tests, revealed no statistically difference between the developed spectrofluorimetric methods and the comparison methods regarding the accuracy and precision, so can be contributed to the analysis of apixaban and tirofiban HCl in QC laboratories as an alternative method.
Apixaban and Tirofiban Hydrochloride are low molecular weight anticoagulants. The two drugs exhibit native fluorescence that allow the development of simple and valid spectrofluorimetric methods for the determination of Apixaban at λ ex/λ em=284/450nm and tirofiban HCl at λ ex/λ em=227/300nm in aqueous media. Different experimental parameters affecting fluorescence intensities were carefully studied and optimized. The fluorescence intensity-concentration plots were linear over the ranges of 0.2–6μgml−1 for apixaban and 0.2–5μgml−1 for tirofiban HCl. The limits of detection were 0.017 and 0.019μgml−1 and quantification limits were 0.057 and 0.066μgml−1 for apixaban and tirofiban HCl, respectively. The fluorescence quantum yield of apixaban and tirofiban were calculated with values of 0.43 and 0.49. Method validation was evaluated for linearity, specificity, accuracy, precision and robustness as per ICH guidelines. The proposed spectrofluorimetric methods were successfully applied for the determination of apixaban in Eliquis tablets and tirofiban HCl in Aggrastat intravenous infusion. Tolerance ratio was tested to study the effect of foreign interferences from dosage forms excipients. Using Student's t and F tests, revealed no statistically difference between the developed spectrofluorimetric methods and the comparison methods regarding the accuracy and precision, so can be contributed to the analysis of apixaban and tirofiban HCl in QC laboratories as an alternative method. [Display omitted] •New validated spectrofluorimetric methods for the analysis of selected anticoagulants.•The developed methods are successfully applied for the analysis of selected drugs in drug substances and drug products.•The methods are based on the measurements of the native fluorescence of selected drugs.•The proposed methods can be used as alternative methods in quality control laboratories.
Author Elkady, Ehab F.
El-Bagary, Ramzia I.
Youssef, Nadia F.
Farid, Naira A.
Author_xml – sequence: 1
  givenname: Ramzia I.
  surname: El-Bagary
  fullname: El-Bagary, Ramzia I.
  organization: Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University, Egypt
– sequence: 2
  givenname: Ehab F.
  surname: Elkady
  fullname: Elkady, Ehab F.
  organization: Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt
– sequence: 3
  givenname: Naira A.
  surname: Farid
  fullname: Farid, Naira A.
  email: nairaahmed49@yahoo.com
  organization: Pharmaceutical Chemistry Department, National organization for Drug Control and Research (NODCAR), Giza, Egypt
– sequence: 4
  givenname: Nadia F.
  surname: Youssef
  fullname: Youssef, Nadia F.
  organization: Pharmaceutical Chemistry Department, National organization for Drug Control and Research (NODCAR), Giza, Egypt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27984753$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtqHDEQRUWwyXhsf0A2QT_QbZXUDw1ZBZOHweCN7a3Qo5rW0N1qJE2It_lyazKJl15VFdQ9VJ0tOVvCgoR8AlYDg-5mXyeta17aGqBmjfxALkD2ohJt25-VXsiugoa3G7JNac8YA8nZR7Lh_U42fSsuyJ9nPXmnMzqaVrQ5hmE6hOhnzNFbWsoYXKJDiDSPSB1mjLNfdPZhoWGgevW_tdEL1Yuj2Ze4P07ji4vBjlMhOaR-oeuo46wtHrK3ejry5sP0l5KuyPmgp4TX_-olefr-7fH2Z3X_8OPu9ut9ZUUrcmUGBtwK7LjegZUdSCP61rTcDD3jojFGDrw3fYccTMuYlDswrtFSQoOsPHtJ4MS1MaQUcVBr-VPHFwVMHX2qvSo-1dGnAlDFZ8l8PmXWg5nRvSX-CywLX04LWC7_5TGqZD0uFp2PRadywb-DfwVoHotA
CitedBy_id crossref_primary_10_1016_j_saa_2023_122473
crossref_primary_10_1016_j_pharma_2021_06_002
crossref_primary_10_1021_acsomega_2c07790
crossref_primary_10_1515_revac_2023_0058
crossref_primary_10_1007_s10895_020_02616_w
crossref_primary_10_1016_j_saa_2018_11_028
crossref_primary_10_1038_s41598_022_25917_5
crossref_primary_10_1039_D3RA03293K
crossref_primary_10_1016_j_saa_2021_120207
crossref_primary_10_1016_j_molliq_2017_10_139
crossref_primary_10_1002_bmc_4719
crossref_primary_10_1155_2024_2675736
crossref_primary_10_1016_j_nantod_2021_101186
Cites_doi 10.1016/S0731-7085(96)01848-1
10.1016/j.jpba.2013.02.007
10.1016/j.saa.2016.01.029
10.1016/j.jchromb.2004.03.003
10.4236/ajac.2015.66052
10.3797/scipharm.1403-25
ContentType Journal Article
Copyright 2016 Elsevier B.V.
Copyright © 2016 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 Elsevier B.V.
– notice: Copyright © 2016 Elsevier B.V. All rights reserved.
DBID NPM
AAYXX
CITATION
DOI 10.1016/j.saa.2016.11.048
DatabaseName PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
DatabaseTitleList PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Physics
EISSN 1873-3557
EndPage 330
ExternalDocumentID 10_1016_j_saa_2016_11_048
27984753
S1386142516307119
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1~.
1~5
4.4
457
4G.
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AAXUO
ABMAC
ABYKQ
ACDAQ
ACRLP
ADBBV
ADECG
ADEZE
AEBSH
AEKER
AFKWA
AFTJW
AFZHZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCB
SDF
SDG
SDP
SES
SPC
SPCBC
SSK
SSZ
T5K
WH7
XPP
ZMT
~G-
NPM
1RT
53G
6TJ
AAQXK
AAXKI
AAYXX
ABFNM
ABXDB
ACNNM
ADMUD
AFJKZ
ASPBG
AVWKF
AZFZN
CITATION
FGOYB
HZ~
M36
R2-
SEW
UHS
ID FETCH-LOGICAL-c353t-bf012c3e62a91c8618b375b52bf70234bb8f27b76e21b5008891bd4a8814e0753
IEDL.DBID AIKHN
ISSN 1386-1425
IngestDate Thu Sep 26 16:17:26 EDT 2024
Wed Oct 16 01:00:25 EDT 2024
Fri Feb 23 02:32:01 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Tirofiban HCl
Method validation
Spectrofluorimetry
Apixaban
Pharmaceutical formulations
Language English
License Copyright © 2016 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-bf012c3e62a91c8618b375b52bf70234bb8f27b76e21b5008891bd4a8814e0753
PMID 27984753
PageCount 5
ParticipantIDs crossref_primary_10_1016_j_saa_2016_11_048
pubmed_primary_27984753
elsevier_sciencedirect_doi_10_1016_j_saa_2016_11_048
PublicationCentury 2000
PublicationDate 2017-03-05
PublicationDateYYYYMMDD 2017-03-05
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
PublicationTitleAlternate Spectrochim Acta A Mol Biomol Spectrosc
PublicationYear 2017
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Țilea, Popa, Xantus, Primejdie, Grigorescu, Țilea, Bocicor, Varga (bb0035) 2015; 23
Brayfield (bb0005) 2014
Brunton, Chabner, Knollman, Weitz (bb0010) 2011
Gandhimathi, Athotiand, Ravi (bb0050) 2013; 3
Tantawy, El-Ragehy, Hassan, Abdelkawy (bb0020) 2016; 159
bb0095
Agarwal (bb0110) 2013; 279
Chen, Huang, Zheng, Xu, Wang (bb0090) 1990; 17
PRABHUNE, JAGUSTE, KONDALKAR, PRADHAN (bb0025) 2014; 82
Darkovska, Emilija, Zorica, Icko, Nenad (bb0060) 2014; 4
Rong-fu, Chi, Jun-feng, Qing (bb0045) 2010
Ellis, Hand, Gilbert (bb0075) 1997; 15
Delavenne, Mismetti, Basset (bb0040) 2013; 78–79
Katzung, Masters, Trevor, Zehnder (bb0015) 2012
Ranjitha, Rao (bb0055) 2011; 1
NATARAJ, SAI KUMAR, KALYANI, DUZA (bb0070) 2013; 5
(bb0100) 2015
Oertel, Kohler, Koste, Kirch (bb0080) 2004; 805
International conference on Harmonization (ICH) Q2 (bb0085) 2005
Yang-jie, Lei, Qi-ming (bb0065) 2013; 33
Landge, Jadhav, Dahale, Solanki, Bembalkar, Mathad (bb0030) 2015; 6
(bb0105) 2015
28315823 - Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jun 15;181:23
PRABHUNE (10.1016/j.saa.2016.11.048_bb0025) 2014; 82
Ranjitha (10.1016/j.saa.2016.11.048_bb0055) 2011; 1
Agarwal (10.1016/j.saa.2016.11.048_bb0110) 2013; 279
(10.1016/j.saa.2016.11.048_bb0105) 2015
Brayfield (10.1016/j.saa.2016.11.048_bb0005) 2014
Rong-fu (10.1016/j.saa.2016.11.048_bb0045) 2010
NATARAJ (10.1016/j.saa.2016.11.048_bb0070) 2013; 5
Delavenne (10.1016/j.saa.2016.11.048_bb0040) 2013; 78–79
Chen (10.1016/j.saa.2016.11.048_bb0090) 1990; 17
(10.1016/j.saa.2016.11.048_bb0100) 2015
Ellis (10.1016/j.saa.2016.11.048_bb0075) 1997; 15
Țilea (10.1016/j.saa.2016.11.048_bb0035) 2015; 23
Darkovska (10.1016/j.saa.2016.11.048_bb0060) 2014; 4
Brunton (10.1016/j.saa.2016.11.048_bb0010) 2011
International conference on Harmonization (ICH) Q2 (10.1016/j.saa.2016.11.048_bb0085) 2005
Yang-jie (10.1016/j.saa.2016.11.048_bb0065) 2013; 33
Tantawy (10.1016/j.saa.2016.11.048_bb0020) 2016; 159
Katzung (10.1016/j.saa.2016.11.048_bb0015) 2012
Oertel (10.1016/j.saa.2016.11.048_bb0080) 2004; 805
Landge (10.1016/j.saa.2016.11.048_bb0030) 2015; 6
Gandhimathi (10.1016/j.saa.2016.11.048_bb0050) 2013; 3
References_xml – year: 2015
  ident: bb0100
  article-title: In-house Specification for the Analysis of Apixaban
  publication-title: Megafine
– volume: 33
  start-page: 1012
  year: 2013
  end-page: 1015
  ident: bb0065
  article-title: HPLC determination of tirofiban using chiral mobile phase
  publication-title: Chinese Journal of Pharmaceutical Analysis
  contributor:
    fullname: Qi-ming
– start-page: 601
  year: 2012
  ident: bb0015
  article-title: Basic & Clinical Pharmacology, 12th ed
  contributor:
    fullname: Zehnder
– volume: 3
  start-page: 9310
  year: 2013
  end-page: 9315
  ident: bb0050
  article-title: Three newer methods for the estimation of tirofiban hydrochloride from pharmaceutical formulation
  publication-title: IAJPR
  contributor:
    fullname: Ravi
– volume: 279
  start-page: 189
  year: 2013
  ident: bb0110
  article-title: Basic Statistics
  contributor:
    fullname: Agarwal
– volume: 78–79
  start-page: 150
  year: 2013
  end-page: 153
  ident: bb0040
  article-title: Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study
  publication-title: J. Pharm. Biomed. Anal.
  contributor:
    fullname: Basset
– volume: 4
  start-page: 115
  year: 2014
  end-page: 120
  ident: bb0060
  article-title: Development and validation of reverse phase high performance liquid chromatographic method for determination of tirofiban in serum
  publication-title: IJPP
  contributor:
    fullname: Nenad
– volume: 23
  start-page: 115
  year: 2015
  end-page: 125
  ident: bb0035
  article-title: Determination of apixaban levels in human plasma by a high-throughput liquid chromatographic tandem mass spectrometry assay
  publication-title: RJLabM
  contributor:
    fullname: Varga
– year: 2010
  ident: bb0045
  article-title: Determination of tirofiban hydrochloride/sodium chloride injection by UV spectrophotometry
  publication-title: Journal of china pharmacy
  contributor:
    fullname: Qing
– year: 2005
  ident: bb0085
  article-title: (R1): Validation of Analytical Procedures Test and Methodology, Geneva, Switzerland
  contributor:
    fullname: International conference on Harmonization (ICH) Q2
– volume: 6
  start-page: 539
  year: 2015
  end-page: 550
  ident: bb0030
  article-title: Development and validation of stability indicating RP-HPLC method on core shell column for determination of degradation and process related impurities of apixaban—an anticoagulant drug
  publication-title: AJAC
  contributor:
    fullname: Mathad
– volume: 1
  start-page: 43
  year: 2011
  end-page: 47
  ident: bb0055
  article-title: Development and validation of new rp-hplc method for the determination of tirofiban in pharmaceutical formulation
  publication-title: IJPCBS
  contributor:
    fullname: Rao
– volume: 805
  start-page: 181
  year: 2004
  end-page: 185
  ident: bb0080
  article-title: Determination of tirofiban in human serum by liquid chromatography–tandem mass spectrometry
  publication-title: J. Chromatogr. B
  contributor:
    fullname: Kirch
– year: 2015
  ident: bb0105
  article-title: In-house Specification for the Analysis of Tirofiban
  publication-title: Gland chemical private LTD
– start-page: 849
  year: 2011
  ident: bb0010
  article-title: Goodman&Gliman's: The pharmacological Basis of Therapeutics, 12th ed
  contributor:
    fullname: Weitz
– volume: 82
  start-page: 777
  year: 2014
  end-page: 785
  ident: bb0025
  article-title: Stability-indicating high-performance liquid chromatographic determination of apixaban in the presence of degradation products
  publication-title: Sci. Pharm.
  contributor:
    fullname: PRADHAN
– volume: 15
  start-page: 561
  year: 1997
  end-page: 569
  ident: bb0075
  article-title: Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma
  publication-title: J Pharm Biomed Anal
  contributor:
    fullname: Gilbert
– volume: 159
  start-page: 13
  year: 2016
  end-page: 20
  ident: bb0020
  article-title: Stability-indicating spectrophotometric methods for determination of the anticoagulant drug apixaban in the presence of its hydrolytic degradation product
  publication-title: Spectrochim. Acta: Part A, Molecular and Biomolecular Spectroscopy
  contributor:
    fullname: Abdelkawy
– volume: 5
  start-page: 200
  year: 2013
  end-page: 203
  ident: bb0070
  article-title: Development and validation of a reverse phase high performance liquid chromatographic method for the estimation of tirofiban in pharmaceutical dosage forms
  publication-title: Int J Ph Ph Sci
  contributor:
    fullname: DUZA
– year: 2014
  ident: bb0005
  article-title: Martindale: the Complete Drug Reference, 38th ed, volume A
  contributor:
    fullname: Brayfield
– volume: 17
  year: 1990
  ident: bb0090
  article-title: Method of Fluorescence Analysis
  contributor:
    fullname: Wang
– ident: bb0095
– volume: 23
  start-page: 115
  issue: 1
  year: 2015
  ident: 10.1016/j.saa.2016.11.048_bb0035
  article-title: Determination of apixaban levels in human plasma by a high-throughput liquid chromatographic tandem mass spectrometry assay
  publication-title: RJLabM
  contributor:
    fullname: Țilea
– volume: 15
  start-page: 561
  issue: 5
  year: 1997
  ident: 10.1016/j.saa.2016.11.048_bb0075
  article-title: Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/S0731-7085(96)01848-1
  contributor:
    fullname: Ellis
– start-page: 601
  year: 2012
  ident: 10.1016/j.saa.2016.11.048_bb0015
  contributor:
    fullname: Katzung
– start-page: 849
  year: 2011
  ident: 10.1016/j.saa.2016.11.048_bb0010
  contributor:
    fullname: Brunton
– volume: 78–79
  start-page: 150
  year: 2013
  ident: 10.1016/j.saa.2016.11.048_bb0040
  article-title: Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2013.02.007
  contributor:
    fullname: Delavenne
– volume: 159
  start-page: 13
  year: 2016
  ident: 10.1016/j.saa.2016.11.048_bb0020
  article-title: Stability-indicating spectrophotometric methods for determination of the anticoagulant drug apixaban in the presence of its hydrolytic degradation product
  publication-title: Spectrochim. Acta: Part A, Molecular and Biomolecular Spectroscopy
  doi: 10.1016/j.saa.2016.01.029
  contributor:
    fullname: Tantawy
– volume: 1
  start-page: 43
  issue: 1
  year: 2011
  ident: 10.1016/j.saa.2016.11.048_bb0055
  article-title: Development and validation of new rp-hplc method for the determination of tirofiban in pharmaceutical formulation
  publication-title: IJPCBS
  contributor:
    fullname: Ranjitha
– volume: 5
  start-page: 200
  issue: 1
  year: 2013
  ident: 10.1016/j.saa.2016.11.048_bb0070
  article-title: Development and validation of a reverse phase high performance liquid chromatographic method for the estimation of tirofiban in pharmaceutical dosage forms
  publication-title: Int J Ph Ph Sci
  contributor:
    fullname: NATARAJ
– year: 2015
  ident: 10.1016/j.saa.2016.11.048_bb0100
  article-title: In-house Specification for the Analysis of Apixaban
  publication-title: Megafine
– volume: 805
  start-page: 181
  issue: 1
  year: 2004
  ident: 10.1016/j.saa.2016.11.048_bb0080
  article-title: Determination of tirofiban in human serum by liquid chromatography–tandem mass spectrometry
  publication-title: J. Chromatogr. B
  doi: 10.1016/j.jchromb.2004.03.003
  contributor:
    fullname: Oertel
– volume: 17
  year: 1990
  ident: 10.1016/j.saa.2016.11.048_bb0090
  contributor:
    fullname: Chen
– year: 2015
  ident: 10.1016/j.saa.2016.11.048_bb0105
  article-title: In-house Specification for the Analysis of Tirofiban
  publication-title: Gland chemical private LTD
– year: 2010
  ident: 10.1016/j.saa.2016.11.048_bb0045
  article-title: Determination of tirofiban hydrochloride/sodium chloride injection by UV spectrophotometry
  publication-title: Journal of china pharmacy
  contributor:
    fullname: Rong-fu
– volume: 6
  start-page: 539
  year: 2015
  ident: 10.1016/j.saa.2016.11.048_bb0030
  article-title: Development and validation of stability indicating RP-HPLC method on core shell column for determination of degradation and process related impurities of apixaban—an anticoagulant drug
  publication-title: AJAC
  doi: 10.4236/ajac.2015.66052
  contributor:
    fullname: Landge
– volume: 3
  start-page: 9310
  issue: 11
  year: 2013
  ident: 10.1016/j.saa.2016.11.048_bb0050
  article-title: Three newer methods for the estimation of tirofiban hydrochloride from pharmaceutical formulation
  publication-title: IAJPR
  contributor:
    fullname: Gandhimathi
– volume: 82
  start-page: 777
  year: 2014
  ident: 10.1016/j.saa.2016.11.048_bb0025
  article-title: Stability-indicating high-performance liquid chromatographic determination of apixaban in the presence of degradation products
  publication-title: Sci. Pharm.
  doi: 10.3797/scipharm.1403-25
  contributor:
    fullname: PRABHUNE
– volume: 33
  start-page: 1012
  issue: 6
  year: 2013
  ident: 10.1016/j.saa.2016.11.048_bb0065
  article-title: HPLC determination of tirofiban using chiral mobile phase
  publication-title: Chinese Journal of Pharmaceutical Analysis
  contributor:
    fullname: Yang-jie
– year: 2005
  ident: 10.1016/j.saa.2016.11.048_bb0085
  contributor:
    fullname: International conference on Harmonization (ICH) Q2
– year: 2014
  ident: 10.1016/j.saa.2016.11.048_bb0005
  contributor:
    fullname: Brayfield
– volume: 4
  start-page: 115
  issue: 4
  year: 2014
  ident: 10.1016/j.saa.2016.11.048_bb0060
  article-title: Development and validation of reverse phase high performance liquid chromatographic method for determination of tirofiban in serum
  publication-title: IJPP
  contributor:
    fullname: Darkovska
– volume: 279
  start-page: 189
  year: 2013
  ident: 10.1016/j.saa.2016.11.048_bb0110
  contributor:
    fullname: Agarwal
SSID ssj0001820
Score 2.307776
Snippet Apixaban and Tirofiban Hydrochloride are low molecular weight anticoagulants. The two drugs exhibit native fluorescence that allow the development of simple...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 326
SubjectTerms Apixaban
Method validation
Pharmaceutical formulations
Spectrofluorimetry
Tirofiban HCl
Title Validated spectrofluorimetric methods for the determination of apixaban and tirofiban hydrochloride in pharmaceutical formulations
URI https://dx.doi.org/10.1016/j.saa.2016.11.048
https://www.ncbi.nlm.nih.gov/pubmed/27984753
Volume 174
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFH5iRdO4TFC2wTaQDztNSlvbceIcUTVUQK2QtqLeIjt21CBIq7VIcOHAX7738qMqFw47RY5kJ3rPet97yefvAfzIlBtECU8CI6IkCGWuAm1zHUiTOGGwIlGVmM54Eo2m4eVMzXZg2J6FIVplE_vrmF5F6-ZOv7Fmf1kU_d9casQWxOcI9ykn6c9dhCOhO7B7dnE1mmwCMmmUV3WXjgKa0P7crGheK0PqQzzqkZYndQF6E562sOd8Hz42SSM7q9_rAHZ82YUPw7ZXWxfeV0TObHUILzeYWFMV71h1iBLD7N3DgjT8SYqf1Q2jVwxTVYapH3MtG4b8wxY5M8vi0VhTMlM6ti6oozeN5k-OemsRXc95VpRsOd_-Fk7r3TeNwFafYHr-689wFDR9FoJMKrkObI4olUkfCZPwDI2qrYyVVcLmMUJ6aK3ORWzjyAtu1YCIUdy60GjNQ48ph_wMnXJR-iNgbuD0wKsYr3Tq1VjSspEe40KsRBbyY_jZmjdd1nIaacszu03RFyn5AsuSFH1xDGHrgPTVnkgx3L817UvtrM0TRJwgCCv59f8W_AZ7gsCcmGfqO3TWfx_8CaYia3sK73rP_LTZcDiaXI__AQaB3sk
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZQESoLgvIqTw9MSKG1HSfOWFWglkIXHuoW2bGjBkFa0SLByi_nLg8ECwNTlEh2Ip9z313y3XeEnCXSdoOIRZ7mQeT5IpWeMqnyhI4s15CRyEJM53YcDB7864mcrJB-XQuDtMrK95c-vfDW1ZVOtZqdeZZ17phQgC2AzwHsU4bSn6sQDUTwdq72hqPB-Nsho0Z5kXepwMMB9c_Ngua10Kg-xIIL1PLELkB_wtMP7LnaJBtV0Eh75XNtkRWXt0izX_dqa5G1gsiZLLbJ5yME1pjFW1oUUYKbfX6boYY_SvHTsmH0gkKoSiH0o7Zmw6B96Cylep69a6NzqnNLlxl29Maz6YfF3lpI17OOZjmdT39-C8f5XqpGYIsd8nB1ed8feFWfBS8RUiw9kwJKJcIFXEcsgUVVRoTSSG7SECDdN0alPDRh4DgzsovEKGasr5VivoOQQ-ySRj7L3T6htmtV18kQjlj1qg1q2QgHfiGUPPFZm5zXyxvPSzmNuOaZPcVgixhtAWlJDLZoE782QPxrT8Tg7v8atlca6_sOPIwAhKU4-N-Ep6Q5uL-9iW-G49EhWecI7MhCk0eksXx9c8cQlizNSbXtvgAwwd-x
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validated+spectrofluorimetric+methods+for+the+determination+of+apixaban+and+tirofiban+hydrochloride+in+pharmaceutical+formulations&rft.jtitle=Spectrochimica+acta.+Part+A%2C+Molecular+and+biomolecular+spectroscopy&rft.au=El-Bagary%2C+Ramzia+I.&rft.au=Elkady%2C+Ehab+F.&rft.au=Farid%2C+Naira+A.&rft.au=Youssef%2C+Nadia+F.&rft.date=2017-03-05&rft.issn=1386-1425&rft.volume=174&rft.spage=326&rft.epage=330&rft_id=info:doi/10.1016%2Fj.saa.2016.11.048&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_saa_2016_11_048
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1386-1425&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1386-1425&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1386-1425&client=summon